Market Research Report - 239930
US Market for Diabetes Monitoring, Treatment and Drug Delivery 2014 (2010-2020)
|Published by||iData Research Inc.|
|Published||Content info||226 Pages|
|US Market for Diabetes Monitoring, Treatment and Drug Delivery 2014 (2010-2020)|
|Published: May 1, 2014||Content info: 226 Pages||
According to the Center for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death among Americans as of 2014. Moreover, diagnosed diabetes had an estimated cost of over $245 billion in the U.S. in 2013. The prevalence of the disease led to a market size for diabetes monitoring, treatment and drug delivery of over $16.7 billion. This market will grow in conjunction with the number of diagnosed diabetics. Some segments will grow faster than others as the demand for modern and more efficient products is increasing faster than the rate of new diabetics. Conversely, reimbursement cuts and declining prices in some segments will affect the market negatively.
This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. Market.
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.